Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Regency Centers
REG
$13.9B
| $878K | ﹤0.01% |
14,800
-389,169
| -96% | -$25.8M |
|
2802
iShares MSCI Chile ETF
ECH
$1.03B
| $876K | ﹤0.01% |
36,390
+19,990
| +122% | +$545K |
|
2803
MediWound
MDWD
$179M
| $875K | ﹤0.01% |
67,917
+2,514
| +4% | +$33.3K |
|
2804
Alamo Group
ALG
$2.01B
| $873K | ﹤0.01% |
+7,500
| New | +$919K |
|
2805
iShares ESG Aware MSCI USA ETF
ESGU
$18.5B
| $873K | ﹤0.01% |
+10,400
| New | +$950K |
|
2806
Solid Biosciences
SLDB
$972M
| $873K | ﹤0.01% |
94,595
+10,023
| +12% | +$104K |
|
2807
Stagwell
STGW
$2.29B
| $872K | ﹤0.01% |
160,600
+63,400
| +65% | +$449K |
|
2808
Vanguard Financials ETF
VFH
$14B
| $872K | ﹤0.01% |
+11,300
| New | +$954K |
|
|
RBCN
2809
DELISTED
Rubicon Technology, Inc.
RBCN
| $870K | ﹤0.01% |
94,679
-2,100
| -2% | -$19.2K |
|
|
SACH
2810
Sachem Capital Corp
SACH
$38.4M
| $869K | ﹤0.01% |
212,900
-236,342
| -53% | -$1.11M |
|
|
JCTC
2811
Jewett-Cameron Trading
JCTC
$10.3M
| $869K | ﹤0.01% |
137,928
-1,800
| -1% | -$12.5K |
|
|
ADAP
2812
DELISTED
Adaptimmune Therapeutics
ADAP
| $867K | ﹤0.01% |
510,000
-449,703
| -47% | -$772K |
|
2813
Lisata Therapeutics
LSTA
$10.6M
| $861K | ﹤0.01% |
108,239
+7,749
| +8% | +$63.8K |
|
2814
Midland States Bancorp
MSBI
$698M
| $861K | ﹤0.01% |
35,808
+28,300
| +377% | +$738K |
|
|
FRGE
2815
DELISTED
Forge Global Holdings
FRGE
| $859K | ﹤0.01% |
5,500
+727
| +15% | +$195K |
|
|
AAIC
2816
DELISTED
Arlington Asset Investment Corp.
AAIC
| $850K | ﹤0.01% |
261,549
+23,200
| +10% | +$77.4K |
|
|
REE
2817
DELISTED
REE Automotive
REE
| $849K | ﹤0.01% |
24,403
+7,983
| +49% | +$408K |
|
2818
iShares US Medical Devices ETF
IHI
$3.48B
| $847K | ﹤0.01% |
+16,800
| New | +$916K |
|
2819
Health Catalyst
HCAT
$135M
| $846K | ﹤0.01% |
58,400
-278,669
| -83% | -$4.75M |
|
2820
Nomura Holdings
NMR
$29B
| $846K | ﹤0.01% |
236,290
+108,600
| +85% | +$415K |
|
2821
Nortech Systems
NSYS
$42.5M
| $845K | ﹤0.01% |
60,359
-3,800
| -6% | -$44.8K |
|
2822
Viant Technology
DSP
$264M
| $843K | ﹤0.01% |
165,900
-56,792
| -26% | -$340K |
|
2823
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $843K | ﹤0.01% |
20,600
+6,300
| +44% | +$286K |
|
2824
Pliant Therapeutics
PLRX
$66.3M
| $842K | ﹤0.01% |
105,100
-500
| -0.5% | -$3.2K |
|
2825
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.43B
| $840K | ﹤0.01% |
7,973
-327
| -4% | -$37.1K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.